Hexarelin — synthetic hexapeptide GHS research compound. Cardiac receptor activity in addition to GH release.

Hexarelin (Examorelin) is a hexapeptide GHS research compound. It has unique characteristics among GHS — including documented activity at cardiac CD36 receptors in addition to pituitary GHS-R1a.
Hexarelin binds GHS-R1a similarly to other GHRPs but also engages cardiac CD36 receptors, making it of dual research interest for both GH release and cardiovascular research.
Used in: GHS-R1a research, CD36 cardiac research, comparative GHRP studies, cardiovascular peptide research.
| Compound | Hexarelin |
| Available Strengths | 2mg, 5mg, 10mg |
| Purity | ≥99% (verified by HPLC) |
| Form | Lyophilized powder |
| Storage | -20°C, protected from light |
| Reconstitution | Bacteriostatic water (sold separately) |
| Shelf Life | 36 months (lyophilized, properly stored) |
| Certificate of Analysis | Available upon request — contact us |
Add bacteriostatic water slowly. Use within 28 days.
Lyophilized: -20°C. Reconstituted: 2-8°C.
For research use only. Not for human consumption.